Dr Kola Tytler MBBS CertHE MBA MRCGPClinical Lead • iatroX
For a patient presenting with hyperglycaemia in primary care, the recommended initial investigations include:
- Confirming hyperglycaemia diagnosis: Measure blood glucose levels, preferably plasma glucose, as patient-held glucose meters are calibrated to plasma glucose equivalents NICE NG17,NICE NG18.
- Assess diabetes subtype: In adults, make an initial clinical diagnosis considering features such as ketosis, rapid weight loss, age of onset under 50 years, BMI below 25 kg/m2, and personal or family history of autoimmune disease NICE NG17.
- Diabetes-specific autoantibodies: Measure these in adults with an initial diagnosis of type 1 diabetes to support classification, ideally quantitative tests for at least two different autoantibodies NICE NG17.
- Serum C-peptide: Not routinely measured at initial diagnosis but considered if diabetes classification remains uncertain, especially if autoantibody tests are negative NICE NG17.
- HbA1c measurement: To assess average blood glucose control over 2–3 months and support diagnosis and management planning NICE CKS,NICE CKS.
- Urine albumin:creatinine ratio (ACR): To detect proteinuria as a marker of kidney damage and cardiovascular risk, ideally from a morning urine sample NICE CKS,NICE CKS.
- Serum creatinine and estimated glomerular filtration rate (eGFR): To assess kidney function NICE CKS,NICE CKS.
These investigations help confirm the diagnosis, classify the diabetes type, and identify early complications or associated risks to guide management in primary care.
Key References
- NG17 - Type 1 diabetes in adults: diagnosis and management
- NG18 - Diabetes (type 1 and type 2) in children and young people: diagnosis and management
- PH38 - Type 2 diabetes: prevention in people at high risk
- NG3 - Diabetes in pregnancy: management from preconception to the postnatal period
- CKS - Diabetes - type 1
- CKS - Type 1 diabetes